News – Page 2 – GeneTether, Inc.

GeneTether Therapeutics Engages Gad Berdugo, Managing Partner of Explorium Capital LLC, as Advisor to Explore Strategic Alternatives for GeneTether Technology Platform

Vancouver, British Columbia – May 1st, 2023

0

GeneTether Therapeutics Inc. Announces Fiscal Year 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – April 27, 2023

0

GeneTether Therapeutics Inc. Update – From the Desk of the CEO

Vancouver, British Columbia – March 30, 2023

0

February 9, 2023

GeneTether Therapeutics Inc. Announces Commencement of Strategic Review Process

Vancouver, British Columbia – February 08, 2023

0

November 29, 2022

GeneTether Therapeutics Inc. Announces Third Quarter 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – November 25, 2022

0

October 26, 2022

GeneTether Therapeutics Inc. Update – From the Desk of the CEO

Vancouver, British Columbia – October 25, 2022

0

August 25, 2022

GeneTether Therapeutics Inc. Announces Second Quarter 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – August 24, 2022

0

GeneTether Therapeutics Announces Issuance of New US Composition of Matter Patent for its Innovative Platform Technology Focused on Gene Editing Efficiency

San Lorenzo, California and Vancouver, British Columbia – May 25, 2022

0

GeneTether Therapeutics Inc. Announces First Quarter 2022 Financial Results and Reports on Corporate Highlights

Vancouver, British Columbia – May 26, 2022

0

GeneTether Therapeutics Publishes Paper on Novel Recombination Products in the CFTR Gene

San Lorenzo, California – May 11, 2022

0